A detailed history of Blue Zone Wealth Advisors, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Blue Zone Wealth Advisors, LLC holds 60,078 shares of CTLT stock, worth $3.55 Million. This represents 1.21% of its overall portfolio holdings.

Number of Shares
60,078
Previous 60,551 0.78%
Holding current value
$3.55 Million
Previous $3.4 Million 6.87%
% of portfolio
1.21%
Previous 1.25%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$56.16 - $60.96 $26,563 - $28,834
-473 Reduced 0.78%
60,078 $3.64 Million
Q2 2024

Jul 12, 2024

SELL
$53.58 - $57.02 $91,032 - $96,876
-1,699 Reduced 2.73%
60,551 $3.4 Million
Q1 2024

Apr 17, 2024

BUY
$42.56 - $59.82 $2,596 - $3,649
61 Added 0.1%
62,250 $3.51 Million
Q4 2023

Jan 09, 2024

BUY
$32.18 - $46.57 $2 Million - $2.9 Million
62,189 New
62,189 $2.79 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.6B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Blue Zone Wealth Advisors, LLC Portfolio

Follow Blue Zone Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Zone Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blue Zone Wealth Advisors, LLC with notifications on news.